AMGEN Inc
NASDAQ: AMGN
$318.89
-$8.47 (-2.6%)
Closing Price on March 11, 2025
AMGN Articles
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech stocks increased.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for the large cap leaders in the group.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated:
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar market.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Abercrombie & Fitch, Amgen, Electronic Arts, General Motors, Goldcorp, Shopify, 3D Systems and Under Armour.
Published:
Last Updated:
The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
Published:
Last Updated:
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated:
CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.
Published:
Last Updated:
AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.